Ogilvie syndrome medical therapy: Difference between revisions
Jump to navigation
Jump to search
Line 15: | Line 15: | ||
=== Medical therapy === | === Medical therapy === | ||
==== Neostigmine ==== | |||
* The first management approach of Ogilvie's syndrome is the supportive care. If the pseudo-obstruction remains refractory, neostigmine is recommended. | |||
* Neostigmine is an antidote, cholinergic cholinesterase inhibitor and autonomic central nervous system agent that is FDA approved for the treatment of the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery.<ref name="pmid17377607">{{cite journal| author=Rausch ME, Troiano NH, Rosen T| title=Use of neostigmine to relieve a suspected colonic pseudoobstruction in pregnancy. | journal=J Perinatol | year= 2007 | volume= 27 | issue= 4 | pages= 244-6 | pmid=17377607 | doi=10.1038/sj.jp.7211669 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17377607 }}</ref> | |||
* Common adverse reactions include hypotension, nausea, bradycardia, and vomiting. Hereby, atropine should be administrated when need for adverse effects reversal.<ref name="pmid16268965">{{cite journal| author=Saunders MD, Kimmey MB| title=Systematic review: acute colonic pseudo-obstruction. | journal=Aliment Pharmacol Ther | year= 2005 | volume= 22 | issue= 10 | pages= 917-25 | pmid=16268965 | doi=10.1111/j.1365-2036.2005.02668.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16268965 }}</ref> | |||
* Preferred regimen: 2mg slow IV infusion for interval of 3 to 5 minutes. | |||
=== Decompression techniques === | |||
* A last management approach (before the surgical option) for the colonic pseudo-obstruction is the non surgical decompression of the obstruction. | |||
* Non surgical decompression can be performed through the following: | |||
** Colonoscopic decompression:<ref name="pmid1473414">{{cite journal| author=Jetmore AB, Timmcke AE, Gathright JB, Hicks TC, Ray JE, Baker JW| title=Ogilvie's syndrome: colonoscopic decompression and analysis of predisposing factors. | journal=Dis Colon Rectum | year= 1992 | volume= 35 | issue= 12 | pages= 1135-42 | pmid=1473414 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1473414 }}</ref> | |||
*** Although decompression of the obstruction using the colonoscopy is difficult, it has shown high success rates in some studies. | |||
*** Colonoscopic decompression must be performed carefully due to risk of perforation. Moreover, no administration of oral substances or enemas before the colonoscopy procedure to prevent the risk of aspiration. | |||
** Percutaneous decompression : | |||
*** | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Needs content]] | [[Category:Needs content]] |
Revision as of 18:52, 6 February 2018
Ogilvie syndrome Microchapters
|
Diagnosis |
---|
Treatment |
Case Studies |
Ogilvie syndrome medical therapy On the Web |
American Roentgen Ray Society Images of Ogilvie syndrome medical therapy |
Risk calculators and risk factors for Ogilvie syndrome medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
Medical Therapy
Supportive care
- Supportive care is recommended in patients with colonic pseduo-obstruction in order to prevent the development of serious complications like intestinal perforation. It can be performed in the first few days after diagnosing the colonic pseudo-obstruction as long as there is no severe pain or extreme abdominal distension.[1]
- The supportive measures include the following:[2]
- Following up and management any underlying cause like heart failure or infection
- Terminating any concurrent medication that may cause intestinal dysmotility like opoids and calcium channel blockers
- Administration of intravenous saline and fluids in order to preserve the normal body homeostasis
- Placement of the patients in a prone position with elevation of the hips
Medical therapy
Neostigmine
- The first management approach of Ogilvie's syndrome is the supportive care. If the pseudo-obstruction remains refractory, neostigmine is recommended.
- Neostigmine is an antidote, cholinergic cholinesterase inhibitor and autonomic central nervous system agent that is FDA approved for the treatment of the reversal of the effects of non-depolarizing neuromuscular blocking agents after surgery.[3]
- Common adverse reactions include hypotension, nausea, bradycardia, and vomiting. Hereby, atropine should be administrated when need for adverse effects reversal.[4]
- Preferred regimen: 2mg slow IV infusion for interval of 3 to 5 minutes.
Decompression techniques
- A last management approach (before the surgical option) for the colonic pseudo-obstruction is the non surgical decompression of the obstruction.
- Non surgical decompression can be performed through the following:
- Colonoscopic decompression:[5]
- Although decompression of the obstruction using the colonoscopy is difficult, it has shown high success rates in some studies.
- Colonoscopic decompression must be performed carefully due to risk of perforation. Moreover, no administration of oral substances or enemas before the colonoscopy procedure to prevent the risk of aspiration.
- Percutaneous decompression :
- Colonoscopic decompression:[5]
References
- ↑ Eisen GM, Baron TH, Dominitz JA, Faigel DO, Goldstein JL, Johanson JF; et al. (2002). "Acute colonic pseudo-obstruction". Gastrointest Endosc. 56 (6): 789–92. PMID 12447286.
- ↑ Sloyer AF, Panella VS, Demas BE, Shike M, Lightdale CJ, Winawer SJ; et al. (1988). "Ogilvie's syndrome. Successful management without colonoscopy". Dig Dis Sci. 33 (11): 1391–6. PMID 3180976.
- ↑ Rausch ME, Troiano NH, Rosen T (2007). "Use of neostigmine to relieve a suspected colonic pseudoobstruction in pregnancy". J Perinatol. 27 (4): 244–6. doi:10.1038/sj.jp.7211669. PMID 17377607.
- ↑ Saunders MD, Kimmey MB (2005). "Systematic review: acute colonic pseudo-obstruction". Aliment Pharmacol Ther. 22 (10): 917–25. doi:10.1111/j.1365-2036.2005.02668.x. PMID 16268965.
- ↑ Jetmore AB, Timmcke AE, Gathright JB, Hicks TC, Ray JE, Baker JW (1992). "Ogilvie's syndrome: colonoscopic decompression and analysis of predisposing factors". Dis Colon Rectum. 35 (12): 1135–42. PMID 1473414.